Biblio

Author Title [ Type

] Year

Filters: Author is Binder, Mascha [Clear All Filters]

Journal Article

von Felden J, Alric L, Pischke S, Aitken C, Schlabe S, Spengler U, Giordani MTeresa, Schnitzler P, Bettinger D, Thimme R, et al. The Burden of Hepatitis E among Patients with Hematological Malignancies: a Retrospective European Cohort Study. J Hepatol. 2019.

Schaffrath J, Diederichs T, Unverzagt S, Wass M, Gläser U, Weber T, Binder M, Müller-Tidow C, Müller LP. Correlation of nutrition-associated parameters with non-relapse mortality in allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2021.

Thiele B, Kloster M, Alawi M, Indenbirken D, Trepel M, Grundhoff A, Binder M. Next-generation sequencing of peripheral B-lineage cells pinpoints the circulating clonotypic cell pool in multiple myeloma. Blood. 2014.

Thiele B, Binder M, Schliffke S, Frenzel C, Dierlamm J, Wass M, Weisel KC, Bokemeyer C, Janjetovic S. Outcome of a Real-World Patient Cohort with Secondary CNS Lymphoma Treated with High-Intensity Chemoimmunotherapy and Autologous Stem Cell Transplantation. Oncol Res Treat. 2021:1-6.

Katzerke C, Schaffrath J, Lützkendorf J, Janssen M, Merbach AKathrin, Nerger K, Binder M, Baum C, Lauer K, Rohde C, et al. Reduced proliferation of bone marrow MSC after allogeneic stem cell transplantation is associated with clinical outcome. Blood Adv. 2023.

Brandt A, Schultheiss C, Klinghammer K, Schafhausen P, Busch C-J, Blaurock M, Hinke A, Tometten M, Dietz A, Müller-Richter U, et al. Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab - the randomized phase 2 FOCUS trial. Front Oncol. 2024;14:1283266.